About
Technology
Issues
FAQ
Links
Official Page
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.